Emboline公司获Trinity Capital 2000万美元成长资本,支持Emboliner®栓塞保护系统商业化以降低TAVR手术卒中风险

美股速递
Mar 11

Emboline公司近日成功获得来自Trinity Capital Inc.的2000万美元成长资本融资。此项资金将专项用于推进其创新产品Emboliner®栓塞保护系统的商业化进程。该系统的核心价值在于通过先进技术有效降低经导管主动脉瓣置换术(TAVR)过程中可能引发的卒中风险。

此次融资将加速Emboliner®系统在临床应用的推广,为接受TAVR手术的患者提供更全面的脑血管保护方案。随着全球TAVR手术量的持续增长,该产品的市场前景备受瞩目。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10